Clincosm LogoSign in Get a demo

covid-19

Showing NaN - NaN of 67
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in United States (Danicopan, Placebo, Remdesivir)

Completed
  • COVID-19
  • Birmingham, Alabama
  • +38 more
Jul 21, 2022

2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in United States (Famotidine,

Terminated
  • 2019 Novel Coronavirus Disease
  • +11 more
  • Newport Beach, California
  • +14 more
Jul 20, 2022

COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)

Active, not recruiting
Has Results
  • COVID-19
  • SARS-CoV-2
  • AZD1222
  • Placebo
  • Phoenix, Arizona
  • +83 more
Jul 13, 2022

COVID-19 Trial in Worldwide (SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1, SARS-CoV-2 recombinant protein

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1
  • +10 more
  • Birmingham, Alabama
  • +71 more
Jul 11, 2022

COVID-19 Trial in Worldwide (PF-07321332, Placebo for PF-07321332, Placebo for Ritonavir)

Completed
  • COVID-19
  • Pelham, Alabama
  • +168 more
Jul 6, 2022

COVID-19 Trial in Argentina, Puerto Rico, United States (Bamlanivimab, Etesevimab, Placebo)

Completed
Has Results
  • COVID-19
  • Birmingham, Alabama
  • +140 more
Jun 7, 2022

COVID-19 Trial in Worldwide (Standard of care, Apremilast, Apremilast )

Completed
Has Results
  • COVID-19
  • Standard of care
  • +6 more
  • Anniston, Alabama
  • +58 more
Jun 23, 2022

COVID-19 Trial in Worldwide (Baricitinib, Dexamethasone, Placebo)

Completed
Has Results
  • COVID-19
  • Birmingham, Alabama
  • +71 more
Jun 22, 2022

COVID-19 Trial in Chicago (Tocilizumab)

Completed
Has Results
  • COVID-19
  • Chicago, Illinois
    University of Chicago Medicine
May 13, 2022

COVID-19 & Psychiatry: A Retrospective Chart Review

Enrolling by invitation
  • COVID-19
  • No intervention
  • Chicago, Illinois
    Northwester Clinical Research Program
Jun 8, 2022

Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised Trial in Worldwide (DAS181, Placebo, DAS181 COVID-19)

Recruiting
  • Lower Respiratory Tract Infection
  • +3 more
  • Duarte, California
  • +59 more
Jun 3, 2022

COVID-19 Trial in Chicago (Tocilizumab, Standard of Care)

Recruiting
  • COVID-19
  • Chicago, Illinois
    University of Chicago Medicine
May 11, 2022

COVID, Covid-19, Coronavirus Trial in Brazil, United States (APL-9, Vehicle Control)

Completed
Has Results
  • COVID
  • +8 more
  • Fresno, California
  • +23 more
Mar 21, 2022

COVID-19 Trial in Worldwide (Placebo, Remdesivir)

Completed
Has Results
  • COVID-19
  • Birmingham, Alabama
  • +59 more
Mar 9, 2022

COVID-19 Trial in Worldwide (Interferon beta-1a, Placebo, Remdesivir)

Completed
Has Results
  • COVID-19
  • Interferon beta-1a
  • +2 more
  • Birmingham, Alabama
  • +63 more
Mar 9, 2022

COVID-19 Trial in Worldwide (Placebo, Remdesivir, Baricitinib)

Completed
Has Results
  • COVID-19
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +70 more
Mar 9, 2022

COVID-19 Trial in United States (Apixaban 2.5 MG, Apixaban 5MG, Aspirin)

Terminated
Has Results
  • COVID-19
  • Apixaban 2.5 MG
  • +3 more
  • Los Angeles, California
  • +70 more
Feb 15, 2022

COVID-19 Trial in United States (CytoSorb 300 mL device)

Completed
  • COVID-19
  • CytoSorb 300 mL device
  • Aurora, Colorado
  • +6 more
Jan 20, 2022

COVID-19 Trial in Russian Federation, United States (Placebo, Ruxolitinib)

Terminated
Has Results
  • COVID-19
  • Scottsdale, Arizona
  • +35 more
Jan 14, 2022

COVID-19 Trial in United States (Camostat Mesilate, Placebo)

Completed
Has Results
  • COVID-19
  • Camostat Mesilate
  • Placebo
  • Palm Springs, California
  • +20 more
Jan 13, 2022

COVID-19 Trial in Worldwide (RDV, Placebo to Match RDV)

Terminated
Has Results
  • COVID-19
  • RDV
  • Placebo to Match RDV
  • Chandler, Arizona
  • +103 more
Nov 4, 2021

COVID-19, SARS-CoV 2 Trial in United States (Hydroxychloroquine (HCQ), Azithromycin (Azithro), Placebo for Hydroxychloroquine)

Terminated
Has Results
  • COVID-19
  • SARS-CoV 2
  • Hydroxychloroquine (HCQ)
  • +3 more
  • Birmingham, Alabama
  • +10 more
Nov 12, 2021

COVID-19 Trial in United States (Hydroxychloroquine, Placebo oral tablet)

Completed
Has Results
  • COVID-19
  • Aurora, Colorado
  • +33 more
Oct 8, 2021

Covid-19 Trial in United States (HCQ, HCQ+AZT, Placebo)

Completed
Has Results
  • Covid-19
  • Fullerton, California
  • +6 more
Oct 7, 2021

SARS-CoV-2/COVID-19 Prevalence Study

Completed
  • COVID-19
    • Aurora, Colorado
    • +14 more
    Sep 29, 2021